These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2465953)

  • 1. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
    Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis].
    Hochhaus A; Mindner K; Ostermann G; Höche D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):765-70. PubMed ID: 1713878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders.
    Emiliani C; Ciferri S; Mencarelli S; Mezzasoma AM; Momi S; Orlacchio A; Gresele P
    Platelets; 2006 Feb; 17(1):20-9. PubMed ID: 16308183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts?
    Grignani C; Noris P; Tinelli C; Barosi G; Balduini CL
    Platelets; 2009 Mar; 20(2):131-4. PubMed ID: 19235056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders.
    Yamamoto K; Sekiguchi E; Takatani O
    Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
    Murphy S; Davis JL; Walsh PN; Gardner FH
    Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
    Ryningen A; Apelseth T; Hausken T; Bruserud Ø
    Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
    Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
    Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal aggregation and increased size of platelets in myeloproliferative disorders.
    Cortelazzo S; Barbui T; Bassan R; Dini E
    Thromb Haemost; 1980 Jun; 43(2):127-30. PubMed ID: 7455970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
    Zuk E
    Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
    Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
    Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet membrane fatty acids in thrombocytosis due to myeloproliferative disorders.
    Leoncini G; Maresca M; Balestrero F; Benatti U; Armani U; Piana A
    Cell Biochem Funct; 1984 Jan; 2(1):23-5. PubMed ID: 6467512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Megakaryocytic myelosis--clinical aspects, morphology and platelet function].
    Hochhaus A; Höche D; Mindner K; Ostermann G; Meyer M
    Klin Wochenschr; 1989 Jan; 67(2):51-9. PubMed ID: 2921844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased response to arachidonic acid and U-46619 and resistance to inhibitory prostaglandins in patients with chronic myeloproliferative disorders.
    Cortelazzo S; Galli M; Castagna D; Viero P; de Gaetano G; Barbui T
    Thromb Haemost; 1988 Feb; 59(1):73-6. PubMed ID: 3129810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of platelet aggregation abnormalities in thrombocytosis after thrombocytopheresis.
    Fabris F; Belloni M; Casonato A; Randi M; Ongaro G; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):853-62. PubMed ID: 6176511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of platelets in the pathogenesis of thrombosis and hemorrhage in patients with thrombocytosis.
    Walsh PN; Murphy S; Barry WE
    Thromb Haemost; 1977 Dec; 38(4):1085-96. PubMed ID: 579686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood platelet and "extra-platelet" serotonin in some myeloproliferative disorders.
    Culebras Poza JM; Launay JM; Briere J; Dreux C
    Biomedicine; 1977 Nov; 27(8):300-3. PubMed ID: 597565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
    Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
    J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytosis: age dependent aetiology and analysis of platelet indices for differential diagnosis.
    Syed NN; Usman M; Khurshid M
    Indian J Pathol Microbiol; 2007 Jul; 50(3):628-33. PubMed ID: 17883167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet abnormalities in myeloproliferative disorders.
    Holme S; Murphy S
    Clin Lab Med; 1990 Dec; 10(4):873-88. PubMed ID: 2272179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.